Allozyne Receives New Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=da419c99-6e8d-4779-95c1-f47d48cf6fb9&Preview=1
Date
12/23/2011
Company Name
Allozyne
Mailing Address
1600 Fairview Ave E Seattle, WA 98102
Company Description
Allozyne, Inc., is a privately held biotechnology company focused on the development and manufacture of protein therapeutics. These technologies will enable the company to improve the efficacy of protein-based therapeutics.
Website
http://www.allozyne.com
Transaction Type
Venture Equity
Transaction Amount
Undisclosed
Transaction Round
Undisclosed
Proceeds Purposes
Funding proceeds will be used to help the company move its multiple sclerosis drug into phase III clinical trials.
M&A Terms
Venture Investor
ARCH Venture Partners
Venture Investor
MPM Capital
Venture Investor
OVP Venture Partners